Cita APA

Pla-Juher, H. (2024). TGFβI gene promoter methylation as a biomarker of resistance to anti-HER2 therapies in HER2-positive breast cancer.

Citación estilo Chicago

Pla-Juher, Helena. TGFβI Gene Promoter Methylation As a Biomarker of Resistance to Anti-HER2 Therapies in HER2-positive Breast Cancer. 2024.

Cita MLA

Pla-Juher, Helena. TGFβI Gene Promoter Methylation As a Biomarker of Resistance to Anti-HER2 Therapies in HER2-positive Breast Cancer. 2024.